Effects of dopamine D2/D3 receptor antagonism on human planning and spatial working memory
- PMID: 28440817
- PMCID: PMC5416697
- DOI: 10.1038/tp.2017.56
Effects of dopamine D2/D3 receptor antagonism on human planning and spatial working memory
Abstract
Psychopharmacological studies in humans suggest important roles for dopamine (DA) D2 receptors in human executive functions, such as cognitive planning and spatial working memory (SWM). However, studies that investigate an impairment of such functions using the selective DA D2/3 receptor antagonist sulpiride have yielded inconsistent results, perhaps because relatively low doses were used. We believe we report for the first time, the effects of a higher (800 mg p.o.) single dose of sulpiride as well as of genetic variation in the DA receptor D2 gene (DA receptor D2 Taq1A polymorphism), on planning and working memory. With 78 healthy male volunteers, we apply a between-groups, placebo-controlled design. We measure outcomes in the difficult versions of the Cambridge Neuropsychological Test Automated Battery One-Touch Stockings of Cambridge and the self-ordered SWM task. Volunteers in the sulpiride group showed significant impairments in planning accuracy and, for the more difficult problems, in SWM. Sulpiride administration speeded response latencies in the planning task on the most difficult problems. Volunteers with at least one copy of the minor allele (A1+) of the DA receptor D2 Taq1A polymorphism showed better SWM capacity, regardless of whether they received sulpiride or placebo. There were no effects on blood pressure, heart rate or subjective sedation. In sum, a higher single dose of sulpiride impairs SWM and executive planning functions, in a manner independent of the DA receptor D2 Taq1A polymorphism.
Conflict of interest statement
UM discloses consultancy for Janssen-Cilag, Lilly, Heptares and Shire, and educational funding from AstraZeneca, Bristol-Myers Squibb, Janssen-Cilag, Lilly, Lundbeck and Pharmacia-Upjohn. AL is an employee of Medpace Medical Device B.V. LC is the Director of the Centre for Gambling Research at UBC, which is supported by the Province of BC government and the British Columbia Lottery Corporation, and has consulted for Cambridge Cognition Ltd. TWR discloses consultancy with Lilly, Lundbeck, Teva, Shire Pharmaceuticals, ChemPartners and Cambridge Cognition Ltd and research grants with Lilly, Lundbeck and GlaxoSmithKline. The remaining authors declare no conflict of interest.
Figures
Similar articles
-
Impaired set-shifting and dissociable effects on tests of spatial working memory following the dopamine D2 receptor antagonist sulpiride in human volunteers.Psychopharmacology (Berl). 2004 Nov;176(3-4):331-42. doi: 10.1007/s00213-004-1899-2. Epub 2004 Apr 28. Psychopharmacology (Berl). 2004. PMID: 15114435 Clinical Trial.
-
Role of dopamine D2 receptors in human reinforcement learning.Neuropsychopharmacology. 2014 Sep;39(10):2366-75. doi: 10.1038/npp.2014.84. Epub 2014 Apr 9. Neuropsychopharmacology. 2014. PMID: 24713613 Free PMC article. Clinical Trial.
-
Sulpiride and mnemonic function: effects of a dopamine D2 receptor antagonist on working memory, emotional memory and long-term memory in healthy volunteers.J Psychopharmacol. 2005 Jan;19(1):29-38. doi: 10.1177/0269881105048889. J Psychopharmacol. 2005. PMID: 15671126 Clinical Trial.
-
Dopamine D2 receptor occupancy levels of acute sulpiride challenges that produce working memory and learning impairments in healthy volunteers.Psychopharmacology (Berl). 2008 Jan;196(1):157-65. doi: 10.1007/s00213-007-0947-0. Epub 2007 Oct 3. Psychopharmacology (Berl). 2008. PMID: 17912501 Clinical Trial.
-
The role of central dopamine D3 receptors in drug addiction: a review of pharmacological evidence.Brain Res Brain Res Rev. 2005 Jul;49(1):77-105. doi: 10.1016/j.brainresrev.2004.12.033. Brain Res Brain Res Rev. 2005. PMID: 15960988 Free PMC article. Review.
Cited by
-
Blocking D2/D3 dopamine receptors in male participants increases volatility of beliefs when learning to trust others.Nat Commun. 2023 Jul 8;14(1):4049. doi: 10.1038/s41467-023-39823-5. Nat Commun. 2023. PMID: 37422466 Free PMC article.
-
Effects of dopamine D2/3 and opioid receptor antagonism on the trade-off between model-based and model-free behaviour in healthy volunteers.Elife. 2022 Dec 5;11:e79661. doi: 10.7554/eLife.79661. Elife. 2022. PMID: 36468832 Free PMC article.
-
Pramipexole modulates fronto-subthalamic pathway in sequential working memory.Neuropsychopharmacology. 2023 Apr;48(5):716-723. doi: 10.1038/s41386-022-01494-z. Epub 2022 Nov 9. Neuropsychopharmacology. 2023. PMID: 36352204 Free PMC article. Clinical Trial.
-
Migraine Pharmacological Treatment and Cognitive Impairment: Risks and Benefits.Int J Mol Sci. 2022 Sep 27;23(19):11418. doi: 10.3390/ijms231911418. Int J Mol Sci. 2022. PMID: 36232720 Free PMC article. Review.
-
Striatal dopamine dissociates methylphenidate effects on value-based versus surprise-based reversal learning.Nat Commun. 2022 Aug 24;13(1):4962. doi: 10.1038/s41467-022-32679-1. Nat Commun. 2022. PMID: 36002446 Free PMC article.
References
-
- Brozoski TJ, Brown RM, Rosvold HE, Goldman PS. Cognitive deficit caused by regional depletion of dopamine in prefrontal cortex of rhesus monkey. Science 1979; 205: 929–932. - PubMed
-
- Dias R, Robbins TW, Roberts AC. Dissociation in prefrontal cortex of affective and attentional shifts. Nature 1996; 380: 69–72. - PubMed
-
- Arnsten AF. Catecholamine modulation of prefrontal cortical cognitive function. Trends Cogn Sci 1998; 2: 436–447. - PubMed
-
- Middleton FA, Strick PL. Anatomical evidence for cerebellar and basal ganglia involvement in higher cognitive function. Science 1994; 266: 458–461. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
